Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women

Gene

Volumn 494, Issue 2, 2012, Pages 168-173

  Jeon, Young Joo ^a   Choi, Yi Seul ^a   Rah, HyungChul ^a   Kim, Su Yeoun ^a   Choi, Dong Hee ^a   Cha, Sun Hee ^a   Shin, Ji Eun ^a   Shim, Sung Han ^a   Lee, Woo Sik ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

Author keywords

Genetic association; MicroRNA (miRNA); Polymorphism; Recurrent spontaneous abortion (RSA)

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A2; MICRORNA 499; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; LIVE BIRTH; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT SPONTANEOUS ABORTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KOREA; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RISK;

EID: 84862782018     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.026     Document Type: Article

References (48)

1. Avery S., Zafarana G., Gokhale P.J., Andrews P.W. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 2010, 28:863-873.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Carcagno A.L., et al. E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation. PLoS One 2011, 6:e21938.
4. Chen C.C., Mo F.E., Lau L.F. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J. Biol. Chem. 2001, 276:47329-47337.
5. Cuellar T.L., McManus M.T. MicroRNAs and endocrine biology. J. Endocrinol. 2005, 187:327-332.
6. Fang Y., Kong B., Yang Q., Ma D., Qu X. MDM2 309 polymorphism is associated with missed abortion. Hum. Reprod. 2009, 24:1346-1349.
7. Fluhr H., Wenig H., Spratte J., Heidrich S., Ehrhardt J., Zygmunt M. Non-apoptotic Fas-induced regulation of cytokines in undifferentiated and decidualized human endometrial stromal cells depends on caspase-activity. Mol. Hum. Reprod. 2011, 17:127-134.
8. Fujino T., et al. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp. Hematol. 2001, 29:856-863.
9. Gregory R.I., Chendrimada T.P., Shiekhattar R. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol. Biol. 2006, 342:33-47.
10. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.
11. He X.Y., Chen J.X., Zhang Z., Li C.L., Peng Q.L., Peng H.M. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J. Cancer Res. Clin. Oncol. 2010, 136:1023-1028.
12. Hoffman A.E., et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009, 69:5970-5977.
13. Hornstein E., et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005, 438:671-674.
14. Hu Z., et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 2009, 30:79-84.
15. Iwai N., Naraba H. Polymorphisms in human pre-miRNAs. Biochem. Biophys. Res. Commun. 2005, 331:1439-1444.
16. Jakobovits A., Shackleford G.M., Varmus H.E., Martin G.R. Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:7806-7810.
17. Kawasaki H., Taira K. MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp. Ser. (Oxf.) 2004, 48:211-212.
18. Lal A., et al. miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 2009, 35:610-625.
19. Lee Y., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
20. Lee S.Y., Chung Y., Elston R.C., Kim Y., Park T. Log-linear model-based multifactor dimensionality reduction method to detect gene-gene interactions. Bioinformatics 2007, 23:2589-2595.
21. Lim L.P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
22. Lin R.J., Lin Y.C., Yu A.L. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol. Carcinog. 2010, 49:719-727.
23. Makker A, Goel MM, Das V, Anjoo Agarwal., (in press). PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol. Endocrinol.
24. Malumbres M., Carnero A. Cell cycle deregulation: a common motif in cancer. Prog. Cell Cycle Res. 2003, 5:5-18.
25. McCallie B., Schoolcraft W.B., Katz-Jaffe M.G. Aberration of blastocyst microRNA expression is associated with human infertility. Fertil. Steril. 2010, 93:2374-2382.
26. Moore J.H., Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 2002, 34:88-95.
27. Moustakas A., Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6733-6738.
28. Murakami A., Ishida S., Thurlow J., Revest J.M., Dickson C. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter. Nucleic Acids Res. 2001, 29:3347-3355.
29. Naidu R., Wahab N.A., Yadav M., Kutty M.K., Nair S., 2001. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Int. J. Mol. Med. 8, 193-198.
30. Oktay K., Kim J.Y., Barad D., Babayev S.N. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J. Clin. Oncol. 2010, 28:240-244.
31. Pan Q., Luo X., Toloubeydokhti T., Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol. Hum. Reprod. 2007, 13:797-806.
32. Pickering M.T., Stadler B.M., Kowalik T.F. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 2009, 28:140-145.
33. Pietrowski D., et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum. Reprod. 2005, 20:848-851.
34. Ritchie M.D., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001, 69:138-147.
35. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
36. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
37. Schimanski C.C., et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J. Gastroenterol. 2009, 2009(15):2089-2096.
38. Sluijter J.P., et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:859-868.
39. Srivatsan E.S., Misra B.C., Venugopalan M., Wilczynski S.P. Loss of heterozygosity for alleles on chromosome II in cervical carcinoma. Am. J. Hum. Genet. 1991, 49:868-877.
40. Stamp G., et al. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Differ. 1992, 3:929-938.
41. Suzuki Y., Kim H.W., Ashraf M., Haider H.Kh. Diazoxide potentiates mesenchymal stem cell survival via NF-κB-dependent miR-146a expression by targeting Fas. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1077-H1082.
42. Vitiello D., Kodaman P.H., Taylor H.S. HOX genes in implantation. Semin. Reprod. Med. 2007, 25:431-436.
43. Wilfred B.R., Wang W.X., Nelson P.T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 2007, 91:209-217.
44. Xu T., et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008, 29:2126-2131.
45. Xu J., et al. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum. Mutat. 2009, 30:1231-1236.
46. Zhang Y., et al. MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am. J. Obstet. Gynecol. 2010, 202:466.
47. Zhong H., et al. Targeting Smad4 links microRNA-146a to the TGF-beta pathway during retinoid acid induction in acute promyelocytic leukemia cell line. Int. J. Hematol. 2010, 92:129-135.
48. Zhou B., et al. Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin. Chim. Acta 2010, 411:1287-1290.